Alpa Laboratories Limited (BOM:532878)

India · Delayed Price · Currency is INR

59.00

-0.09 (-0.15%)

At close: Oct 6, 2026

Market Cap	1.24B -33.8%
Revenue (ttm)	1.11B +0.5%
Net Income	42.22M -83.9%
EPS	2.11 -83.2%
Shares Out	n/a
PE Ratio	29.27
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	287
Open	59.00
Previous Close	59.09
Day's Range	58.02 - 59.59
52-Week Range	46.00 - 99.75
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About Alpa Laboratories

Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It offers ethical, generic, and over the counter medicines. The company provides tablets, capsules, injections, syrups, ointments, creams, eye drops, and other dosage forms for human and veterinary healthcare, as well as aquaculture products, including probiotics, deodorizer, minerals, feed supplements, and disinfectant. The company was founded in 1967 and is based in Indore, India. [Read more]

Industry Pharmaceutical Preparations

Founded 1967

Employees 457

Stock Exchange Bombay Stock Exchange

Ticker Symbol 532878

Full Company Profile

Financial Performance

In fiscal year 2026, Alpa Laboratories's revenue was 1.06 billion, a decrease of -5.91% compared to the previous year's 1.12 billion. Earnings were 150.10 million, a decrease of -23.04%.

Financial Statements